US Stock MarketDetailed Quotes
AMIX Autonomix Medical
- 3.390
- -0.110-3.14%
Close Dec 24 13:00 ET
- 3.350
- -0.040-1.18%
Pre 08:03 ET
6.91MMarket Cap-0.28P/E (TTM)
3.580High3.300Low41.21KVolume3.510Open3.500Pre Close141.76KTurnover3.40%Turnover RatioLossP/E (Static)2.04MShares152.00052wk High2.28P/B4.11MFloat Cap2.88052wk Low--Dividend TTM1.21MShs Float152.000Historical High--Div YieldTTM8.00%Amplitude2.880Historical Low3.439Avg Price1Lot Size
Autonomix Medical Key Stats
Quarterly+Annual
YOY
| (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | |||||||||
| Cash flow from continuing operating activities | -39.51%-1.6M | -180.18%-1.85M | -258.58%-6.65M | -268.87%-2.29M | -2.56M | -1.14M | -661K | -1.85M | -620K |
| Net income from continuing operations | 53.53%-2.81M | -212.02%-2.7M | -675.18%-15.43M | -723.14%-5.41M | ---3.11M | ---6.04M | ---865K | ---1.99M | ---657K |
| Operating gains losses | ---- | ---- | --8M | --3.03M | --178K | ---- | ---- | ---- | ---- |
| Depreciation and amortization | --45K | --43K | --81K | --46K | --35K | --0 | --0 | --0 | --0 |
| Change In working capital | 1,315.69%620K | 117.65%444K | -41.91%79K | -656.76%-206K | --132K | ---51K | --204K | --136K | --37K |
| -Change in payables and accrued expense | 3,892.31%493K | -106.11%-14K | 338.58%557K | -627.03%-195K | --536K | ---13K | --229K | --127K | --37K |
| -Change in other current assets | 434.21%127K | 1,932.00%458K | -5,411.11%-478K | ---11K | ---404K | ---38K | ---25K | --9K | --0 |
| Cash from discontinued investing activities | |||||||||
| Operating cash flow | -39.51%-1.6M | -180.18%-1.85M | -258.58%-6.65M | -268.87%-2.29M | ---2.56M | ---1.14M | ---661K | ---1.85M | ---620K |
| Investing cash flow | |||||||||
| Cash flow from continuing investing activities | 0 | -5K | -19K | -3K | -16K | 0 | 0 | 0 | 0 |
| Net PPE purchase and sale | --0 | ---5K | ---19K | ---3K | ---16K | --0 | --0 | --0 | --0 |
| Cash from discontinued investing activities | |||||||||
| Investing cash flow | --0 | ---5K | ---19K | ---3K | ---16K | --0 | --0 | --0 | --0 |
| Financing cash flow | |||||||||
| Cash flow from continuing financing activities | 0 | 0 | 2,034.81%14.41M | 1,334.07%9.68M | 1.65M | 350K | 2.74M | 675K | 675K |
| Net issuance payments of debt | ---- | ---- | --2M | --0 | --1.65M | ---- | ---- | --0 | --0 |
| Net common stock issuance | --0 | --0 | 1,930.52%13.71M | 1,509.78%10.87M | --0 | --0 | --2.84M | --675K | --675K |
| Net other financing activities | ---- | ---- | ---1.3M | ---1.19M | ---5K | --0 | ---105K | ---- | ---- |
| Cash from discontinued financing activities | |||||||||
| Financing cash flow | --0 | --0 | 2,034.81%14.41M | 1,334.07%9.68M | --1.65M | --350K | --2.74M | --675K | --675K |
| Net cash flow | |||||||||
| Beginning cash position | 129.70%6.75M | 895.14%8.61M | -57.68%865K | 50.37%1.22M | --2.15M | --2.94M | --865K | --2.04M | --810K |
| Current changes in cash | -101.01%-1.6M | -189.54%-1.86M | 756.74%7.74M | 13,336.36%7.39M | ---927K | ---794K | --2.07M | ---1.18M | --55K |
| End cash Position | 140.33%5.16M | 129.70%6.75M | 895.14%8.61M | 895.14%8.61M | --1.22M | --2.15M | --2.94M | --865K | --865K |
| Free cash flow | -39.51%-1.6M | -180.94%-1.86M | -259.60%-6.67M | -269.35%-2.29M | ---2.57M | ---1.14M | ---661K | ---1.85M | ---620K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data